A citation-based method for searching scientific literature

Serena Chao, J Scott Roberts, Theresa M Marteau, Rebecca Silliman, L Adrienne Cupples, Robert C Green. Alzheimer Dis Assoc Disord 2008
Times Cited: 162

List of co-cited articles
596 articles co-cited >1

Times Cited
  Times     Co-cited

Disclosure of APOE genotype for risk of Alzheimer's disease.
Robert C Green, J Scott Roberts, L Adrienne Cupples, Norman R Relkin, Peter J Whitehouse, Tamsen Brown, Susan LaRusse Eckert, Melissa Butson, A Dessa Sadovnick, Kimberly A Quaid,[...]. N Engl J Med 2009

Effect of Alzheimer disease genetic risk disclosure on dietary supplement use.
Jacqueline A Vernarelli, J Scott Roberts, Susan Hiraki, Clara A Chen, L Adrienne Cupples, Robert C Green. Am J Clin Nutr 2010

Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study.
J Scott Roberts, L Adrienne Cupples, Norman R Relkin, Peter J Whitehouse, Robert C Green. J Geriatr Psychiatry Neurol 2005

Effect of direct-to-consumer genomewide profiling to assess disease risk.
Cinnamon S Bloss, Nicholas J Schork, Eric J Topol. N Engl J Med 2011

Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.
Theresa M Marteau, David P French, Simon J Griffin, A T Prevost, Stephen Sutton, Clare Watkinson, Sophie Attwood, Gareth J Hollands. Cochrane Database Syst Rev 2010

Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior.
Cathleen D Zick, Charles J Mathews, J Scott Roberts, Robert Cook-Deegan, Robert J Pokorski, Robert C Green. Health Aff (Millwood) 2005

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013

Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: a randomized controlled trial.
Theresa Marteau, Victoria Senior, Steve E Humphries, Martin Bobrow, Treena Cranston, Martin A Crook, Lorna Day, Maryam Fernandez, Rob Horne, Andrew Iversen,[...]. Am J Med Genet A 2004

Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial.
Richard W Grant, Kelsey E O'Brien, Jessica L Waxler, Jason L Vassy, Linda M Delahanty, Laurie G Bissett, Robert C Green, Katherine G Stember, Candace Guiducci, Elyse R Park,[...]. Diabetes Care 2013

The role of disease perceptions and results sharing in psychological adaptation after genetic susceptibility testing: the REVEAL Study.
Sato Ashida, Laura M Koehly, J Scott Roberts, Clara A Chen, Susan Hiraki, Robert C Green. Eur J Hum Genet 2010

An intervention study of individual, apoE genotype-based dietary and physical-activity advice: impact on health behavior.
Hanna-Leena Hietaranta-Luoma, Raija Tahvonen, Terhi Iso-Touru, Hannu Puolijoki, Anu Hopia. J Nutrigenet Nutrigenomics 2014

The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis.
Gareth J Hollands, David P French, Simon J Griffin, A Toby Prevost, Stephen Sutton, Sarah King, Theresa M Marteau. BMJ 2016

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Reisa A Sperling, Paul S Aisen, Laurel A Beckett, David A Bennett, Suzanne Craft, Anne M Fagan, Takeshi Iwatsubo, Clifford R Jack, Jeffrey Kaye, Thomas J Montine,[...]. Alzheimers Dement 2011

Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants.
Kristin Harkins, Pamela Sankar, Reisa Sperling, Joshua D Grill, Robert C Green, Keith A Johnson, Megan Healy, Jason Karlawish. Alzheimers Res Ther 2015

Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors.
Jill S Goldman, Susan E Hahn, Jennifer Williamson Catania, Susan LaRusse-Eckert, Melissa Barber Butson, Malia Rumbaugh, Michelle N Strecker, J Scott Roberts, Wylie Burke, Richard Mayeux,[...]. Genet Med 2011

Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease.
J Scott Roberts, Susan A LaRusse, Heather Katzen, Peter J Whitehouse, Melissa Barber, Stephen G Post, Norman Relkin, Kimberly Quaid, Robert H Pietrzak, L Adrienne Cupples,[...]. Alzheimer Dis Assoc Disord 2003

A systematic review of perceived risks, psychological and behavioral impacts of genetic testing.
Jodi T Heshka, Crystal Palleschi, Heather Howley, Brenda Wilson, Philip S Wells. Genet Med 2008

Effect of knowledge of APOE genotype on subjective and objective memory performance in healthy older adults.
Tara T Lineweaver, Mark W Bondi, Douglas Galasko, David P Salmon. Am J Psychiatry 2014

Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income.
Colleen M McBride, Gerold Bepler, Isaac M Lipkus, Pauline Lyna, Greg Samsa, Jennifer Albright, Santanu Datta, Barbara K Rimer. Cancer Epidemiol Biomarkers Prev 2002

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
E H Corder, A M Saunders, W J Strittmatter, D E Schmechel, P C Gaskell, G W Small, A D Roses, J L Haines, M A Pericak-Vance. Science 1993

Improved weight management using genetic information to personalize a calorie controlled diet.
Ioannis Arkadianos, Ana M Valdes, Efstathios Marinos, Anna Florou, Rosalynn D Gill, Keith A Grimaldi. Nutr J 2007

Explaining behavior change after genetic testing: the problem of collinearity between test results and risk estimates.
Thomas R Fanshawe, A Toby Prevost, J Scott Roberts, Robert C Green, David Armstrong, Theresa M Marteau. Genet Test 2008

Genetic susceptibility testing for Alzheimer disease: motivation to obtain information and control as precursors to coping with increased risk.
Holly C Gooding, Erin L Linnenbringer, Jeffrey Burack, J Scott Roberts, Robert C Green, Barbara B Biesecker. Patient Educ Couns 2006

Impact of direct-to-consumer genomic testing at long term follow-up.
Cinnamon S Bloss, Nathan E Wineinger, Burcu F Darst, Nicholas J Schork, Eric J Topol. J Med Genet 2013

Genetic testing for Alzheimer's and long-term care insurance.
Donald H Taylor, Robert M Cook-Deegan, Susan Hiraki, J Scott Roberts, Dan G Blazer, Robert C Green. Health Aff (Millwood) 2010

Public perceptions of presymptomatic testing for Alzheimer disease.
Richard J Caselli, Jessica Langbaum, Gary E Marchant, Rachel A Lindor, Katherine S Hunt, Bruce R Henslin, Amylou C Dueck, Jason S Robert. Mayo Clin Proc 2014

Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials.
Scott Y H Kim, Jason Karlawish, Benjamin E Berkman. Neurology 2015

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Billy Dunn, Samantha Budd Haeberlein, David M Holtzman, William Jagust, Frank Jessen, Jason Karlawish,[...]. Alzheimers Dement 2018

Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residents.
Peter J Neumann, Joshua T Cohen, James K Hammitt, Thomas W Concannon, Hannah R Auerbach, Chihui Fang, David M Kent. Health Econ 2012

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
L A Farrer, L A Cupples, J L Haines, B Hyman, W A Kukull, R Mayeux, R H Myers, M A Pericak-Vance, N Risch, C M van Duijn. JAMA 1997

Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease.
Michael R Cassidy, J Scott Roberts, Thomas D Bird, Ellen J Steinbart, L Adrienne Cupples, Clara A Chen, Erin Linnenbringer, Robert C Green. Alzheimers Dement 2008

Psychological, behavioral and social effects of disclosing Alzheimer's disease biomarkers to research participants: a systematic review.
S A S A Bemelmans, K Tromp, E M Bunnik, R J Milne, S Badger, C Brayne, M H Schermer, E Richard. Alzheimers Res Ther 2016

Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study.
L Adrienne Cupples, Lindsay A Farrer, A Dessa Sadovnick, Norman Relkin, Peter Whitehouse, Robert C Green. Genet Med 2004

A randomized trial of genetic information for personalized nutrition.
Daiva E Nielsen, Ahmed El-Sohemy. Genes Nutr 2012

Managing incidental findings and research results in genomic research involving biobanks and archived data sets.
Susan M Wolf, Brittney N Crock, Brian Van Ness, Frances Lawrenz, Jeffrey P Kahn, Laura M Beskow, Mildred K Cho, Michael F Christman, Robert C Green, Ralph Hall,[...]. Genet Med 2012

Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial.
J Scott Roberts, Melissa Barber, Tamsen M Brown, L Adrienne Cupples, Lindsay A Farrer, Susan A LaRusse, Stephen G Post, Kimberly A Quaid, Lisa D Ravdin, Norman R Relkin,[...]. Genet Med 2004

Communicating genetic risk information for common disorders in the era of genomic medicine.
Denise M Lautenbach, Kurt D Christensen, Jeffrey A Sparks, Robert C Green. Annu Rev Genomics Hum Genet 2013

Recommendations for returning genomic incidental findings? We need to talk!
Wylie Burke, Armand H Matheny Antommaria, Robin Bennett, Jeffrey Botkin, Ellen Wright Clayton, Gail E Henderson, Ingrid A Holm, Gail P Jarvik, Muin J Khoury, Bartha Maria Knoppers,[...]. Genet Med 2013

A new initiative on precision medicine.
Francis S Collins, Harold Varmus. N Engl J Med 2015

The A4 study: stopping AD before symptoms begin?
Reisa A Sperling, Dorene M Rentz, Keith A Johnson, Jason Karlawish, Michael Donohue, David P Salmon, Paul Aisen. Sci Transl Med 2014

A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial.
Tiia Ngandu, Jenni Lehtisalo, Alina Solomon, Esko Levälahti, Satu Ahtiluoto, Riitta Antikainen, Lars Bäckman, Tuomo Hänninen, Antti Jula, Tiina Laatikainen,[...]. Lancet 2015

Associations between self-referral and health behavior responses to genetic risk information.
Kurt D Christensen, J Scott Roberts, Brian J Zikmund-Fisher, Sharon Lr Kardia, Colleen M McBride, Erin Linnenbringer, Robert C Green. Genome Med 2015

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet Med 2017

Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial.
Kurt D Christensen, J Scott Roberts, Peter J Whitehouse, Charmaine D M Royal, Thomas O Obisesan, L Adrienne Cupples, Jacqueline A Vernarelli, Deepak L Bhatt, Erin Linnenbringer, Melissa B Butson,[...]. Ann Intern Med 2016

Safety of disclosing amyloid status in cognitively normal older adults.
Jeffrey M Burns, David K Johnson, Edward P Liebmann, Rebecca J Bothwell, Jill K Morris, Eric D Vidoni. Alzheimers Dement 2017

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.